Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	PolarityTE	Kiromic BioPharma	Windtree Therapeutics	Brickell Biotech	Allena Pharmaceuticals
Symbol	NASDAQ:PTE	NASDAQ:KRBP	NASDAQ:WINT	NASDAQ:BBI	NASDAQ:ALNA
Price Information
Current Price	$0.95	$9.37	$2.34	$0.97	$1.23
52 Week Range	Buy	N/A	Buy	Buy	Buy
MarketRank™
Overall Score	1.4	1.0	2.3	1.4	1.3
Analysis Score	3.3	0.0	3.5	3.5	3.4
Community Score	2.7	5.0	5.0	1.3	2.6
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	1.7	1.7	0.0
Earnings & Valuation Score	1.3	0.0	1.3	0.6	0.6
Analyst Ratings
Consensus Recommendation	Buy	N/A	Buy	Buy	Buy
Consensus Price Target	$4.00	N/A	$12.25	$5.50	$10.40
% Upside from Price Target	320.61% upside	N/A	423.50% upside	467.01% upside	745.53% upside
Trade Information
Market Cap	$57.19 million	$68.71 million	$61.44 million	$64.92 million	$69.96 million
Beta	1.29	N/A	0.25	0.34	2.39
Average Volume	8,535,365	22,202	314,095	3,642,228	2,134,093
Sales & Book Value
Annual Revenue	$5.65 million	N/A	$200,000.00	$7.92 million	N/A
Price / Sales	10.12	N/A	307.21	8.20	N/A
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$1.42 per share	N/A	$5.48 per share	$0.97 per share	$0.73 per share
Price / Book	0.67	N/A	0.43	1.00	N/A
Profitability
Net Income	$-92,490,000.00	N/A	$-27,480,000.00	$-23,880,000.00	$-47,340,000.00
EPS	($3.70)	N/A	($2.52)	($5.11)	($2.10)
Trailing P/E Ratio	N/A	0.00	N/A	N/A	N/A
Forward P/E Ratio	N/A	∞	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-674.12%	N/A	N/A	-990.67%	N/A
Return on Equity (ROE)	-169.92%	N/A	-43.46%	-187.45%	-207.07%
Return on Assets (ROA)	-105.62%	N/A	-26.55%	-114.85%	-112.21%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.08%	N/A	0.18%	N/A	0.54%
Current Ratio	3.22%	N/A	2.75%	3.50%	7.99%
Quick Ratio	3.11%	N/A	2.75%	3.50%	7.99%
Ownership Information
Institutional Ownership Percentage	16.51%	N/A	1.59%	5.93%	28.03%
Insider Ownership Percentage	5.50%	N/A	14.91%	10.30%	22.80%
Miscellaneous
Employees	153	11	31	15	41
Shares Outstanding	60.13 million	7.33 million	26.26 million	66.93 million	56.88 million
Next Earnings Date	5/10/2021 (Estimated)	6/30/2021 (Estimated)	5/13/2021 (Estimated)	5/12/2021 (Estimated)	5/12/2021 (Estimated)
Optionable	Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	Eiger BioPharmaceuticals (NASDAQ:EIGR) and Allena Pharmaceuticals (NASDAQ:ALNA) Head-To-Head Survey americanbankingnews.com - April 12 at 8:14 PM
	Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Given Average Rating of "Buy" by Brokerages americanbankingnews.com - April 9 at 9:03 AM
	Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Expected to Announce Earnings of -$0.20 Per Share americanbankingnews.com - April 9 at 8:22 AM
	Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) finance.yahoo.com - April 8 at 9:45 AM
	How Many Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Shares Have Insiders Sold, In The Last Year? nasdaq.com - April 7 at 6:10 PM
	Allena Pharmaceuticals Appoints Mark J. Fitzpatrick to its Board of Directors finance.yahoo.com - April 7 at 8:09 AM
	Allena Pharmaceuticals (NASDAQ:ALNA) Trading Down 8.1% americanbankingnews.com - March 18 at 8:34 PM
	Zacks Investment Research Downgrades Allena Pharmaceuticals (NASDAQ:ALNA) to Sell marketbeat.com - March 12 at 4:27 PM
	Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides ... apnews.com - March 10 at 9:24 AM
	Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update finance.yahoo.com - March 9 at 8:24 AM
	Top Penny Stocks On Robinhood If Biotech Is Your Focus Right Now marketwatch.com - February 24 at 10:48 PM
	Allena Pharmaceuticals to Present at Upcoming Investor Conferences in March finance.yahoo.com - February 24 at 12:46 PM
	Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) On Wednesday – Up 72.37 Percent From Lows, What To Expect Going Ahead? marketingsentinel.com - February 6 at 12:29 PM
	Are Institutions Heavily Invested In Allena Pharmaceuticals, Inc.'s (NASDAQ:ALNA) Shares? finance.yahoo.com - February 5 at 7:51 AM
	Allena Pharmaceuticals Appoints Richard D. Katz, M.D. as Chief Financial Officer finance.yahoo.com - February 2 at 11:59 AM
	Allena Pharmaceuticals Inc. ALNA stockhouse.com - January 22 at 6:09 PM
	Has Allena Pharmaceuticals (ALNA) Outpaced Other Medical Stocks This Year? finance.yahoo.com - January 12 at 5:27 PM
	Allena Pharmaceuticals, Inc. (ALNA) Moves to Buy: Rationale Behind the Upgrade finance.yahoo.com - January 12 at 5:27 PM
	Allena Pharmaceuticals Price to Book Value: ycharts.com - January 10 at 12:58 AM
	Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January finance.yahoo.com - January 4 at 8:19 AM
	Allena Pharmaceuticals Price: ycharts.com - December 31 at 12:18 AM
	Allena Pharmaceuticals Increases Previously Announced Bought Deal to $13.0 Million finance.yahoo.com - December 2 at 12:52 AM
	Allena Pharmaceuticals announces $10M bought deal seekingalpha.com - December 1 at 7:51 PM
	Allena Pharmaceuticals Announces $10.0 Million Bought Deal Offering finance.yahoo.com - December 1 at 7:51 PM
	Allena Pharmaceuticals Announces Appointment of David J. Clark, M.D., M.R.C.P. as Chief Medical Officer finance.yahoo.com - December 1 at 2:51 PM
	Allena Pharma's ALLN-346 shows encouraging action in early-stage study seekingalpha.com - November 30 at 3:45 PM

Date	Company	Brokerage	Action
11/10/2020	PolarityTE	Cantor Fitzgerald	Reiterated Rating
9/8/2020	PolarityTE	Oppenheimer	Reiterated Rating
7/24/2020	PolarityTE	Northland Securities	Reiterated Rating
5/12/2020	PolarityTE	HC Wainwright	Reiterated Rating
11/13/2019	PolarityTE	Piper Jaffray Companies	Lower Price Target
5/13/2019	PolarityTE	National Securities	Lower Price Target
6/26/2020	Windtree Therapeutics	LADENBURG THALM/SH SH	Initiated Coverage
8/28/2020	Brickell Biotech	Lake Street Capital	Initiated Coverage
10/1/2020	Allena Pharmaceuticals	B. Riley	Boost Price Target
9/10/2020	Allena Pharmaceuticals	Wedbush	Reiterated Rating
7/15/2020	Allena Pharmaceuticals	Roth Capital	Reiterated Rating
2/17/2020	Allena Pharmaceuticals	Credit Suisse Group	Reiterated Rating
11/14/2019	Allena Pharmaceuticals	Cowen	Reiterated Rating

(Data available from 4/12/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources